Polatuzumab Vedotin in Combination With Chemotherapy in Subjects With Richter's Transformation (clinicaltrials.gov) - Sep 26, 2026 - P2 | N=20 | Active, not recruiting | Sponsor: Weill Medical College of Cornell University | Recruiting ➔ Active, not recruiting | Trial primary completion date: Sep 2026 ➔ Jan 2027
Enrollment closed • Trial primary completion date • Chronic Lymphocytic Leukemia • Hematological Malignancies • Leukemia • Lymphoma • Oncology • Richter's Syndrome
|